Chemo-Induced Myelosuppression Presentation and Management in ES-SCLCByKennon McCollum, DNPNovember 22nd 2025Kennon McCollum, DNP, explains how multi-day ES-SCLC chemotherapy regimens heighten myelosuppression risk and drive dose delays.